tradmap

DTIL PRECISION BIOSCIENCES INC

$6.79 +4.55%

Healthcare · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC (DTIL) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $175 million. Shares last traded at $6.79, 23.1% below their 52-week high. Over the past year the stock is up 38.5%. Net profit margin is -133.4%, below the peer median of 6.3%. Revenue declined 50.1% year over year.

Market Cap
$175M
Shares Out
25.8M
EPS (TTM)
$-13.43
P/E Ratio
P/S Ratio
5.11
P/B Ratio
2.30
Dividend / Share
Dividend Yield
52-Week High
$8.82
52-Week Low
$3.49
Volume
20,456
Avg Vol (3m)
19,797.032

Performance

1W
+10.33%
1M
-1.67%
3M
+1.19%
6M
+41.35%
YTD
+65.49%
1Y
+38.47%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
50.87
SMA (50)
$7.12
SMA (200)
$5.64
Price vs SMA50
-4.71%
Price vs SMA200
+20.24%
ATR (14)
$0.53

Financials

Revenue
$34M
Net Income
$-46M
Gross Margin
Operating Margin
-152.2%
Net Margin
-133.4%
Return on Equity
-60.1%
Return on Assets
-31.8%
Current Ratio
14.02
Debt / Equity
0.29
Revenue Growth (YoY)
-50.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-0.75 2026-05-05
FY 2025 $-3.56 2026-03-12
Q3 2025 $-6.14 2025-11-03
Q2 2025 $-4.33 2025-08-07
Q1 2026 $-2.21 2026-05-05
FY 2025 $1.04 2026-03-12

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

DTIL vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap.

P/S vs peers
5.11 / 5.21 med
-2% discount
Net margin vs peers
-133.4% / 6.3% med
below median
1–14 of 14
AMGNAmgen$182.1B23.624.9621.0%-1.27%
GILDGilead Sciences$153.5B18.045.2128.9%-1.46%
RVMDRevolution Medicines, Inc.$34.6B-30.62+3.14%
BIIBBiogen$29.0B22.442.9313.1%-1.15%
MRNAModerna$25.4B-8.99+3.22%
NBIXNeurocrine Biosciences Inc$15.9B33.245.5616.7%-0.48%
EXELExelixis, Inc.$13.1B16.685.6233.7%-1.04%
KRYSKrystal Biotech, Inc.$10.2B50.0226.3352.6%+1.68%
TECHBio-Techne$9.1B123.617.446.0%+5.36%
HALOHalozyme Therapeutics, Inc.$8.1B25.675.8222.7%-0.03%
IBRXImmunitybio, Inc.$7.7B-21.87+5.01%
RGENRepligen Corp$7.4B152.2710.086.6%-1.20%
KYMRKymera Therapeutics, Inc.$7.4B23.88+0.44%
PCVXVaxcyte, Inc.$7.4B-9688.00+1.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.